EQT Life Sciences Mergers and Acquisitions Summary

Growth Capital Firm Profile

In the last 3 years, EQT Life Sciences has invested in 2 companies.

EQT Life Sciences’ most common sectors for investment arelife science (64%) and medical products (31%) . The Firm’s most common investment types include venture (85%) and growth capital (9%). In total, EQT Life Sciences has invested in 7 US states and 10 different countries.

The Firm’s most common exit type is trade sale (50%).

Join Mergr to view EQT Life Sciences’ full profile and discover more large growth capital firm investors just like it.

M&A Summary

  • M&A Total Activity48
    • M&A Buy Activity46
    • M&A Sell Activity2
  • Total Sectors Invested 5
  • Total Countries Invested 10
  • M&A Buy/Sell Connections 9

EQT Life Sciences

EQT Life Sciences

Johannes Vermeerplein 9,
Amsterdam, 1071 DV
Netherlands
+31 (0) 20 664 55 00
www.lspvc.com
lspamsterdam@lspvc.com


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Growth Capital, Stake Purchase, Venture

Geographic Preferences: East US, Midwest US, South US, West US, Western Europe

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (2.8/yr) # 32 12 2 - - - 46
Sell (0.2/yr) # 1 1 - - - - 2
  48

Most Recent M&A

Company Date Value Type
Perfuze Ltd. 2022-02-09 - Venture
Galway, Ireland · www.perfuze.com
Nobi BV 2022-01-27 - Growth Capital
Antwerp, Belgium · www.nobi.life
AviadoBio Ltd. 2021-12-08 - Venture
London, United Kingdom · www.aviadobio.com
HotSpot Therapeutics, Inc. 2021-11-30 - Venture
Boston, Massachusetts · www.www.hotspotthera.com
Egle Therapeutics SAS 2021-10-22 - Venture
Paris, France · www.egle-tx.com
Amolyt Pharma 2021-09-16 - Venture
Ecully, France · www.amolytpharma.com
Evommune, Inc. 2021-09-09 - Venture
Los Altos, California · www.evommune.com
Visus Therapeutics, Inc. 2021-08-10 - Venture
Seattle, Washington · www.visustx.com
binx health, inc. 2021-07-21 - Venture
Cambridge, Massachusetts · www.mybinxhealth.com
Muna Therapeutics 2021-07-09 - Venture
Copenhagen , Denmark · www.munatherapeutics.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 27 (63%) - 29 (63%) -
Medical Products 13 (30%) - 14 (30%) -
Healthcare Services 1 (2%) - 1 (2%) -
Information Technology 1 (2%) - 1 (2%) -
Leisure 1 (2%) - 1 (2%) -
Total 43 - 46 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 10 (23%) - 11 (24%) -
  Massachusetts 3 (7%) - 3 (7%) -
  California 2 (5%) - 3 (7%) -
  Washington 1 (2%) - 1 (2%) -
  Rhode Island 1 (2%) - 1 (2%) -
  Pennsylvania 1 (2%) - 1 (2%) -
  North Carolina 1 (2%) - 1 (2%) -
  Illinois 1 (2%) - 1 (2%) -
Netherlands 8 (19%) - 10 (22%) -
Belgium 5 (12%) - 5 (11%) -
Ireland 5 (12%) - 5 (11%) -
France 4 (9%) - 4 (9%) -
Germany 4 (9%) - 4 (9%) -
United Kingdom 2 (5%) - 2 (4%) -
Denmark 2 (5%) - 2 (4%) -
Switzerland 2 (5%) - 2 (4%) -
Sweden 1 (2%) - 1 (2%) -
Total 43 - 46 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 37 (86%) - 39 (85%) -
Growth Capital 4 (9%) - 4 (9%) -
Stake Purchase 1 (2%) - 2 (4%) -
Buyout (LBO, MBO, MBI) 1 (2%) - 1 (2%) -
Total 43 - 46 -

Exits by Deal Type

Type Total # Value
IPO 1 (50%) -
Trade Sale - Public Company 1 (50%) -
Total 2 -

M&A Connections

Deals
Exited to
Strategic(s)
50%
1 (50%)

Investor Summary

Investor Type

Growth Capital Firm

Size

Large

PE Assets

2.0B USD

Established

1987

Specialist/Generalist

Specialist

Subsidiary of

EQT

 Subscribe to unlock this and 193,848
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 184K M&A Transactions
  • 189K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.5K M&A Advisors
    (Investment Banks and Law Firms)
  • 72K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Mergr

Product

Company

Legal